1. Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib. (18th March 2018) Authors: Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta Other Names: Jakovljevic Vladimir Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib". (26th June 2019) Authors: Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta Journal: Oxidative medicine and cellular longevity Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. Issue 4 (5th January 2016) Authors: Ferraro, Elisabetta; Pin, Fabrizio; Gorini, Stefania; Pontecorvo, Laura; Ferri, Alberto; Mollace, Vincenzo; Costelli, Paola; Rosano, Giuseppe Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 7:Issue 4(2016) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26‐bearing mice. Issue 6 (11th November 2017) Authors: Molinari, Francesca; Pin, Fabrizio; Gorini, Stefania; Chiandotto, Sergio; Pontecorvo, Laura; Penna, Fabio; Rizzuto, Emanuele; Pisu, Simona; Musarò, Antonio; Costelli, Paola; Rosano, Giuseppe; Ferraro, Elisabetta Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 8:Issue 6(2017) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathway. Issue 9 (30th July 2020) Authors: Marzolla, Vincenzo; Feraco, Alessandra; Gorini, Stefania; Mammi, Caterina; Marrese, Carmen; Mularoni, Valentina; Boitani, Carla; Lombès, Marc; Kolkhof, Peter; Ciriolo, Maria Rosa; Armani, Andrea; Caprio, Massimiliano Journal: FASEB journal Issue: Volume 34:Issue 9(2020) Page Start: 12450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗